pre-seed
Stage
1
Investors
About
ST Phi Therapeutics is a clinical-stage biotechnology company developing off-the-shelf (universal) engineered T‑cell therapies for oncology, autoimmune and infectious diseases.
Explore ST Phi Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.